Diff between cefadoxime cefuraxime cefparzone which antibitoic will use and for what condition
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from the textbooks. Let me compose a thorough answer.
Cefadroxil vs Cefuroxime vs Cefoperazone - A Complete Comparison
(Note: You likely meant cefadroxil for "cefadoxime," cefuroxime for "cefuraxime," and cefoperazone for "cefparzone" - these are the correct drug names.)
At a Glance
| Feature | Cefadroxil | Cefuroxime | Cefoperazone |
|---|---|---|---|
| Generation | 1st generation | 2nd generation | 3rd generation |
| Route | Oral only | Oral (axetil) / IV / IM | IV / IM only |
| Spectrum | Narrow (gram+) | Intermediate | Broad (gram+ and gram-) |
| Pseudomonas activity | None | None | Yes (some) |
| Biliary excretion | No | No | Yes (primary) |
1. Cefadroxil (1st Generation)
Spectrum:
- Excellent gram-positive coverage: Streptococci, Staphylococci (MSSA, not MRSA)
- Limited gram-negative: only E. coli, Klebsiella pneumoniae, Proteus mirabilis
- No Pseudomonas, no Bacteroides fragilis
- Oral agent similar in activity and pharmacokinetics to cephalexin
Pharmacokinetics:
- Oral administration; well absorbed
- Renally excreted - dose reduction needed in renal failure
Clinical Uses:
- Uncomplicated skin and soft tissue infections (impetigo, folliculitis, cellulitis, erysipelas, ecthyma)
- Uncomplicated UTIs caused by E. coli, Klebsiella, Proteus
- Streptococcal pharyngitis / tonsillitis
- Mild community-acquired wound infections
"A first-generation agent such as cephalexin or cefadroxil is the cephalosporin of choice in uncomplicated skin infections." - Dermatology 2-Volume Set 5e
2. Cefuroxime (2nd Generation)
Spectrum:
- Moderately active against gram-positive cocci (but less than 1st gen)
- Improved gram-negative coverage including H. influenzae (including ampicillin-resistant strains), N. meningitidis, S. pneumoniae, E. coli, Klebsiella
- Does NOT cover B. fragilis (unlike cefoxitin/cefotetan)
- No Pseudomonas activity
Pharmacokinetics:
- Available as cefuroxime (IV/IM) and cefuroxime axetil (oral, 30-50% absorbed)
- ~10% penetrates CSF - can treat meningitis but inferior to ceftriaxone
- Renally cleared; dose adjust in renal failure
Clinical Uses:
- Community-acquired pneumonia (active against H. influenzae and pneumococci)
- Sinusitis, otitis media
- Surgical prophylaxis (cardiac, orthopedic, hysterectomy)
- Lyme disease
- Acute cholecystitis / biliary infections
- Not recommended for meningitis despite CSF penetration (ceftriaxone is preferred)
"Cefuroxime is sometimes used to treat community-acquired pneumonia because it is active against β-lactamase-producing H. influenzae and also many pneumococci." - Katzung's Basic and Clinical Pharmacology, 16th Ed.
3. Cefoperazone (3rd Generation)
Spectrum:
- Broadest of the three
- Active against most Enterobacterales, Citrobacter, Serratia, Providencia
- Useful activity against Pseudomonas aeruginosa (shared only with ceftazidime among 3rd-gen agents)
- Less active against gram-positive cocci compared to 1st/2nd gen
- Active against many β-lactamase-producing H. influenzae and Neisseria
Pharmacokinetics:
- IV/IM only (no oral form)
- Primarily biliary (hepatic) excretion - NO dose adjustment needed in renal failure; dose adjust in hepatic failure
- This biliary route causes more diarrhea than other cephalosporins
- Contains methylthiotetrazole ring - can cause hypoprothrombinemia (vitamin K-dependent bleeding) and disulfiram-like reaction with alcohol
- No longer commercially available in the USA (still used widely outside the US)
Clinical Uses:
- Hospital-acquired gram-negative bacteremia
- Biliary tract infections and acute cholangitis
- Serious intra-abdominal infections
- Pseudomonal infections (when ceftazidime is unavailable)
- Klebsiella and other hospital-acquired gram-negative infections (often used as cefoperazone-sulbactam combination)
- Severe melioidosis (Burkholderia pseudomallei)
"For Pseudomonas aeruginosa, ceftazidime or cefoperazone may succeed. Thus, third-generation drugs are very useful in the management of hospital-acquired gram-negative bacteremia." - Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Ed.
When to Use Which
| Clinical Situation | Drug of Choice |
|---|---|
| Strep throat, mild skin/soft tissue infection | Cefadroxil (oral, 1st gen) |
| Uncomplicated UTI (outpatient) | Cefadroxil |
| Community-acquired pneumonia | Cefuroxime |
| Otitis media, sinusitis | Cefuroxime (oral axetil) |
| Surgical prophylaxis | Cefuroxime (IV) |
| Lyme disease | Cefuroxime (oral) |
| Hospital-acquired gram-negative infection | Cefoperazone (3rd gen) |
| Pseudomonal infection | Cefoperazone (or ceftazidime) |
| Biliary tract / cholangitis | Cefoperazone (hepatic excretion) |
| Intra-abdominal (with Pseudomonas risk) | Cefoperazone-sulbactam |
Key Safety Points
- Cefadroxil: safe, well tolerated, dose-adjust in renal failure
- Cefuroxime: avoid in meningitis (use ceftriaxone instead)
- Cefoperazone: watch for bleeding risk (give vitamin K), avoid alcohol (disulfiram reaction), monitor LFTs in hepatic impairment
Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. | Goodman & Gilman's The Pharmacological Basis of Therapeutics | Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Ed. | Dermatology 2-Volume Set 5e
This is a shared conversation. Sign in to Orris to start your own chat.